Income taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of income before income tax, domestic and foreign [Table Text Block] |
| |
|
2025 |
|
|
2024 |
|
| Canada |
|
(16,817,273 |
) |
|
(6,187,172 |
) |
| Foreign |
|
(18,627,087 |
) |
|
(4,968,344 |
) |
| Loss before income taxes |
|
(35,444,361 |
) |
|
(11,155,516 |
) |
|
| Schedule of effective income tax rate reconciliation [Table Text Block] |
| |
|
% |
|
|
2025 |
|
| Canadian federal statutory income tax rate |
|
15% |
|
|
(5,316,650 |
) |
| Domestic Federal |
|
|
|
|
|
|
| Non-taxable and non-deductible items |
|
(1.6%) |
|
|
568,150 |
|
| Statutory income tax differential |
|
|
|
|
|
|
| Valuation Allowance Federal |
|
(5.5%) |
|
|
1,954,660 |
|
| |
|
|
|
|
|
|
| Domestic provincial income taxes, net of federal effect |
|
0.0% |
|
|
- |
|
| Foreign Tax Effects |
|
|
|
|
|
|
| United States |
|
|
|
|
|
|
| Non-deductible and other expenses |
|
0.0% |
|
|
- |
|
| Statutory income tax rate differential |
|
3.5% |
|
|
(1,228,030 |
) |
| Valuation Allowance United States |
|
(7.0%) |
|
|
2,492,310 |
|
| United Kingdom |
|
|
|
|
|
|
| Statutory income tax differential |
|
2.9% |
|
|
(1,019,710 |
) |
| Valuation Allowance United Kingdom |
|
(7.2%) |
|
|
2,549,270 |
|
| Income tax (benefit) |
|
0.0% |
|
|
- |
|
| |
|
2024 |
|
| Income tax recovery at the statutory rate |
|
(2,956,212 |
) |
| Permanent differences |
|
189,075 |
|
| Impact of tax rate changes |
|
42,865 |
|
| Change in valuation allowance |
|
2,724,272 |
|
| |
|
- |
|
|
| Schedule of income tax (benefit) expense [Table Text Block] |
| |
|
2025 |
|
|
2024 |
|
| Current tax (benefit) expense |
|
- |
|
|
- |
|
| Deferred tax (benefit) expense |
|
- |
|
|
- |
|
| |
|
- |
|
|
- |
|
|
| Schedule of deferred tax assets and liabilities [Table Text Block] |
| |
|
Year ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Non-capital losses carry forward - Canada |
|
5,326,310 |
|
|
1,973,535 |
|
| Net operating losses carryforward - US |
|
6,194,650 |
|
|
2,678,919 |
|
| Net operating losses carryforward - UK |
|
369,910 |
|
|
- |
|
| Intangible assets |
|
10,860 |
|
|
10,855 |
|
| Accrued expenses |
|
766,430 |
|
|
994,653 |
|
| Research and development tax credits |
|
210,610 |
|
|
242,190 |
|
| Other |
|
9,240 |
|
|
14,230 |
|
| Financing charges and interest |
|
1,212,190 |
|
|
668,701 |
|
| Convertible Debentures |
|
106,830 |
|
|
- |
|
| Deferred income tax assets |
|
14,207,007 |
|
|
6,583,083 |
|
| Less: valuation allowance |
|
(14,207,007 |
) |
|
(6,583,083 |
) |
| Deferred income tax assets, net of valuation allowance |
|
- |
|
|
- |
|
|